Samsung Biologics signed a supply contract worth KRW 62.8 billion.

Supply ContractAmended filingFiled Nov 2, 2026

Unofficial English translation by ChickenStock; the Korean original prevails. Korean page · Original filing on DART ↗

Highlights

Structured data

Samsung Biologics signed a supply contract worth KRW 62.8 billion. The contract equals 9% of its recent revenue.

Written in code from the structured data of the filing. Reference information, not investment advice.

Key figures

Contract amount: KRW 62.8 billion
Share of recent revenue: 9%

Filing facts

Filing type: Supply Contract
Report name: [Amended] Single Sales or Supply Contract
Filed: Nov 2, 2026
Receipt number: 20261102800004

Samsung Biologics stock page →Korean page →Original filing on DART ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.